A Patient-Inspired Ex Vivo Liver Tissue Engineering Approach with Autologous Mesenchymal Stem Cells and Hepatogenic Serum

2016 ◽  
Vol 5 (9) ◽  
pp. 1058-1070 ◽  
Author(s):  
Dillip K. Bishi ◽  
Santosh Mathapati ◽  
Jayarama R. Venugopal ◽  
Soma Guhathakurta ◽  
Kotturathu M. Cherian ◽  
...  
2015 ◽  
Vol 25 (s1) ◽  
pp. 137-143 ◽  
Author(s):  
Lei Zhang ◽  
Yong-Hen Zhao ◽  
Zheng Guan ◽  
Jun-Song Ye ◽  
Natalia de Isla ◽  
...  

2006 ◽  
Vol 30 (2) ◽  
pp. 115-118 ◽  
Author(s):  
Toru Morishita ◽  
Kanya Honoki ◽  
Hajime Ohgushi ◽  
Noriko Kotobuki ◽  
Asako Matsushima ◽  
...  

2004 ◽  
Vol 04 (04) ◽  
pp. 463-483 ◽  
Author(s):  
J. C. H. GOH ◽  
X. X. SHAO ◽  
D. W. HUTMACHER ◽  
E. H. LEE

Repair of osteochondral lesions remains difficult in current clinical medicine. This is due to the lack of self-reparatory capacity in adult cartilage to respond to injuries. Furthermore, current surgical based treatment is unable to achieve long-term satisfactory results. Cell therapies combined with scaffolds has become a promising tissue engineering approach for osteochondral regeneration. This article briefly outlines the approaches and limitations in osteochondral tissue engineering from three key aspects, namely: (1) Cells and Cell Source; (2) Biomaterials and Scaffold design and fabrication; and (3) Mechanical and Biochemical Stimulus. Current optimal candidate cells for tissue engineering include bone marrow and adipose tissue derived mesenchymal stem cells. As for scaffolds, the structural design and biomaterials used should support cell growth and the organization of new functional tissue formation. Using Fused Deposition Modeling (FDM) technique, the authors developed a novel polycaprolactone osteochondral scaffold which was shown to have the ability to recruit mesenchymal stem cells and the potential for repairing defects in vivo. The article also discussed mechanical and biological stimulus for enhancing in vitro growth of tissue-engineered constructs. The final challenge is the integration of the tissue-engineered tissues into a living system as a functional device.


2014 ◽  
Vol 20 (17-18) ◽  
pp. 2483-2492 ◽  
Author(s):  
João F. Requicha ◽  
Carlos A. Viegas ◽  
Fernando Muñoz ◽  
Jorge M. Azevedo ◽  
Isabel B. Leonor ◽  
...  

2020 ◽  
Vol 22 (3) ◽  
pp. 35-40
Author(s):  
I. E. Kotkas ◽  
N. I. Enukashvili ◽  
Sh. M. Asadulayev ◽  
A. V. Chubar’

Abstract. The effectiveness of the influence of autologous mesenchymal stem cells on the function of liver tissue in liver cirrhosis of alimentary etiology is considered, as well as the possibility of visualization of the introduced cell structures with subsequent cytological confirmation. To be able to track autologous mesenchymal stem cells introduced in the patients body, they were labeled with iron oxide nanoparticles. Visualization of the introduced cell structures was performed using magnetic resonance imaging and ultrasound examination of the liver. 6 months after the cell therapy, clinical and biochemical blood tests, lidocaine test results, elastography indicators were evaluated, and the dynamics of hepatic encephalopathy was evaluated. The effectiveness of using autologous mesenchymal stem cells was evidenced by the improvement of the above indicators. Also, 6 months after treatment, a liver tissue biopsy was performed from the sites of fixation of previously introduced cell structures. Histological examination revealed the largest number of labeled cells in the liver micro-nodes, as well as at the borders of micro-nodes and fibrous septa. The use of cell therapy in a patient suffering from liver cirrhosis of alimentary etiology helped to improve the indicators of laboratory and instrumental research methods. No complications were detected during the procedure.


Sign in / Sign up

Export Citation Format

Share Document